• Discover Astex
    • Our Mission & Values
    • Our Leadership Team
    • Our History
    • Corporate Social Responsibility
  • R&D
    • Clinical Pipeline
    • Pyramid™ Discovery Platform
    • Oncology and CNS Discovery
    • Sustaining Innovation Postdocs
  • Partnering
  • Our People & Culture
    • Career Opportunities
  • Media
    • Press Releases
    • Conferences & Meetings
    • Presentations & Publications
    • Interactive Scientific Resources
      • Interactive Software
    • Astex in the News
  • Contact
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
You are here: Home1 / Discovery2 / Posters3 / 2012

Nature: Serine is a natural ligand and allosteric activator of pyruvate kinase M2

24 December 2012/in 2012, Discovery

Nature: Serine is a natural ligand and allosteric activator of pyruvate kinase M2

https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2012-12-24 12:17:082024-02-12 16:05:21Nature: Serine is a natural ligand and allosteric activator of pyruvate kinase M2

Pyruvate Kinase M2: linking glycolysis to amino acid biosynthesis

24 November 2012/in 2012, Discovery

Pyruvate Kinase M2: linking glycolysis to amino acid biosynthesis

https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2012-11-24 12:22:462024-02-12 16:05:12Pyruvate Kinase M2: linking glycolysis to amino acid biosynthesis

AACR: Pharmacodynamic and anti-tumor activity of fragment-derived inhibitors of MetAP2

24 October 2012/in 2012, Discovery
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2012-10-24 12:26:172016-11-24 12:58:12AACR: Pharmacodynamic and anti-tumor activity of fragment-derived inhibitors of MetAP2

2012 TAT: Anti-Angiogenic Activity of Fragment-Derived Inhibitors of METAP2

10 March 2012/in 2012

2012 TAT: Anti-Angiogenic Activity of Fragment-Derived Inhibitors of METAP2

https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2012-03-10 09:47:072016-11-25 13:53:562012 TAT: Anti-Angiogenic Activity of Fragment-Derived Inhibitors of METAP2

© Astex Pharmaceuticals
All rights reserved

astex

Useful links

  • Home
  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Legal
  • LinkedIn

Member of the Otsuka Group

A selection of photos on this website
is courtesy of Valerio Berdini

Scroll to top Scroll to top Scroll to top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.